Industry: Pharma & Healthcare
Published Date: 2025-01-01
Pages: 159 Pages
Report ld: 3442779
Request Sample
Customized Report
Valued at US$ 1733 million in 2024, the global Dry Powder Inhalation Excipients market is forecast to reach US$ 2376 million by 2030, at a CAGR of 5.4% during the forecast period.
Dry powder inhalation excipients are auxiliary components used in dry powder inhalation formulations to improve drug dispersion, stability, and inhalation performance. They typically include lactose, mannitol, and other sugars, as well as certain inorganic salts. By optimizing the particle size and distribution of the drug, these excipients enhance the lung deposition rate and bioavailability of the drug. Dry powder inhalation excipients play a crucial role in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease, ensuring effective drug inhalation and therapeutic effects.
The US & Canada market for Dry Powder Inhalation Excipients is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Dry Powder Inhalation Excipients is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Dry Powder Inhalation Excipients is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Dry Powder Inhalation Excipients include Protheragen-ING, DFE Pharma, Meggle-Pharma, Pfanstiehl, Merck, Sheffield (Kerry), Armor Pharma, Abbott, Norvatis, Bayer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Dry Powder Inhalation Excipients, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Dry Powder Inhalation Excipients, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dry Powder Inhalation Excipients, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dry Powder Inhalation Excipients sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Dry Powder Inhalation Excipients market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Dry Powder Inhalation Excipients sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Protheragen-ING, DFE Pharma, Meggle-Pharma, Pfanstiehl, Merck, Sheffield (Kerry), Armor Pharma, Abbott, Norvatis, Bayer, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Dry Powder Inhalation Excipients in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Dry Powder Inhalation Excipients manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dry Powder Inhalation Excipients sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Dry Powder Inhalation Excipients Product Introduction
1.2 Market by Type
1.2.1 Global Dry Powder Inhalation Excipients Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Lactose
1.2.3 Magnesium Stearate
1.2.4 Others
1.3 Market by Application
1.3.1 Global Dry Powder Inhalation Excipients Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 DPI
1.3.3 MDI
1.3.4 Nebulizer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dry Powder Inhalation Excipients Revenue Estimates and Forecasts 2019-2030
2.2 Global Dry Powder Inhalation Excipients Revenue by Region
2.2.1 Global Dry Powder Inhalation Excipients Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Dry Powder Inhalation Excipients Revenue by Region (2019-2024)
2.2.3 Global Dry Powder Inhalation Excipients Revenue by Region (2025-2030)
2.2.4 Global Dry Powder Inhalation Excipients Revenue Market Share by Region (2019-2030)
2.3 Global Dry Powder Inhalation Excipients Sales Estimates and Forecasts 2019-2030
2.4 Global Dry Powder Inhalation Excipients Sales by Region
2.4.1 Global Dry Powder Inhalation Excipients Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Dry Powder Inhalation Excipients Sales by Region (2019-2024)
2.4.3 Global Dry Powder Inhalation Excipients Sales by Region (2025-2030)
2.4.4 Global Dry Powder Inhalation Excipients Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Dry Powder Inhalation Excipients Sales by Manufacturers
3.1.1 Global Dry Powder Inhalation Excipients Sales by Manufacturers (2019-2024)
3.1.2 Global Dry Powder Inhalation Excipients Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dry Powder Inhalation Excipients in 2023
3.2 Global Dry Powder Inhalation Excipients Revenue by Manufacturers
3.2.1 Global Dry Powder Inhalation Excipients Revenue by Manufacturers (2019-2024)
3.2.2 Global Dry Powder Inhalation Excipients Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Dry Powder Inhalation Excipients Revenue in 2023
3.3 Global Key Players of Dry Powder Inhalation Excipients, Industry Ranking, 2021 VS 2022
3.4 Global Dry Powder Inhalation Excipients Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Dry Powder Inhalation Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Dry Powder Inhalation Excipients, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Dry Powder Inhalation Excipients, Product Offered and Application
3.8 Global Key Manufacturers of Dry Powder Inhalation Excipients, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dry Powder Inhalation Excipients Sales by Type
4.1.1 Global Dry Powder Inhalation Excipients Historical Sales by Type (2019-2024)
4.1.2 Global Dry Powder Inhalation Excipients Forecasted Sales by Type (2025-2030)
4.1.3 Global Dry Powder Inhalation Excipients Sales Market Share by Type (2019-2030)
4.2 Global Dry Powder Inhalation Excipients Revenue by Type
4.2.1 Global Dry Powder Inhalation Excipients Historical Revenue by Type (2019-2024)
4.2.2 Global Dry Powder Inhalation Excipients Forecasted Revenue by Type (2025-2030)
4.2.3 Global Dry Powder Inhalation Excipients Revenue Market Share by Type (2019-2030)
4.3 Global Dry Powder Inhalation Excipients Price by Type
4.3.1 Global Dry Powder Inhalation Excipients Price by Type (2019-2024)
4.3.2 Global Dry Powder Inhalation Excipients Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Dry Powder Inhalation Excipients Sales by Application
5.1.1 Global Dry Powder Inhalation Excipients Historical Sales by Application (2019-2024)
5.1.2 Global Dry Powder Inhalation Excipients Forecasted Sales by Application (2025-2030)
5.1.3 Global Dry Powder Inhalation Excipients Sales Market Share by Application (2019-2030)
5.2 Global Dry Powder Inhalation Excipients Revenue by Application
5.2.1 Global Dry Powder Inhalation Excipients Historical Revenue by Application (2019-2024)
5.2.2 Global Dry Powder Inhalation Excipients Forecasted Revenue by Application (2025-2030)
5.2.3 Global Dry Powder Inhalation Excipients Revenue Market Share by Application (2019-2030)
5.3 Global Dry Powder Inhalation Excipients Price by Application
5.3.1 Global Dry Powder Inhalation Excipients Price by Application (2019-2024)
5.3.2 Global Dry Powder Inhalation Excipients Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Dry Powder Inhalation Excipients Market Size by Type
6.1.1 US & Canada Dry Powder Inhalation Excipients Sales by Type (2019-2030)
6.1.2 US & Canada Dry Powder Inhalation Excipients Revenue by Type (2019-2030)
6.2 US & Canada Dry Powder Inhalation Excipients Market Size by Application
6.2.1 US & Canada Dry Powder Inhalation Excipients Sales by Application (2019-2030)
6.2.2 US & Canada Dry Powder Inhalation Excipients Revenue by Application (2019-2030)
6.3 US & Canada Dry Powder Inhalation Excipients Market Size by Country
6.3.1 US & Canada Dry Powder Inhalation Excipients Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Dry Powder Inhalation Excipients Revenue by Country (2019-2030)
6.3.3 US & Canada Dry Powder Inhalation Excipients Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Dry Powder Inhalation Excipients Market Size by Type
7.1.1 Europe Dry Powder Inhalation Excipients Sales by Type (2019-2030)
7.1.2 Europe Dry Powder Inhalation Excipients Revenue by Type (2019-2030)
7.2 Europe Dry Powder Inhalation Excipients Market Size by Application
7.2.1 Europe Dry Powder Inhalation Excipients Sales by Application (2019-2030)
7.2.2 Europe Dry Powder Inhalation Excipients Revenue by Application (2019-2030)
7.3 Europe Dry Powder Inhalation Excipients Market Size by Country
7.3.1 Europe Dry Powder Inhalation Excipients Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Dry Powder Inhalation Excipients Revenue by Country (2019-2030)
7.3.3 Europe Dry Powder Inhalation Excipients Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Dry Powder Inhalation Excipients Market Size by Type
8.1.1 China Dry Powder Inhalation Excipients Sales by Type (2019-2030)
8.1.2 China Dry Powder Inhalation Excipients Revenue by Type (2019-2030)
8.2 China Dry Powder Inhalation Excipients Market Size by Application
8.2.1 China Dry Powder Inhalation Excipients Sales by Application (2019-2030)
8.2.2 China Dry Powder Inhalation Excipients Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Dry Powder Inhalation Excipients Market Size by Type
9.1.1 Asia Dry Powder Inhalation Excipients Sales by Type (2019-2030)
9.1.2 Asia Dry Powder Inhalation Excipients Revenue by Type (2019-2030)
9.2 Asia Dry Powder Inhalation Excipients Market Size by Application
9.2.1 Asia Dry Powder Inhalation Excipients Sales by Application (2019-2030)
9.2.2 Asia Dry Powder Inhalation Excipients Revenue by Application (2019-2030)
9.3 Asia Dry Powder Inhalation Excipients Market Size by Region
9.3.1 Asia Dry Powder Inhalation Excipients Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Dry Powder Inhalation Excipients Revenue by Region (2019-2030)
9.3.3 Asia Dry Powder Inhalation Excipients Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Dry Powder Inhalation Excipients Market Size by Type
10.1.1 Middle East, Africa and Latin America Dry Powder Inhalation Excipients Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Dry Powder Inhalation Excipients Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Dry Powder Inhalation Excipients Market Size by Application
10.2.1 Middle East, Africa and Latin America Dry Powder Inhalation Excipients Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Dry Powder Inhalation Excipients Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Dry Powder Inhalation Excipients Market Size by Country
10.3.1 Middle East, Africa and Latin America Dry Powder Inhalation Excipients Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Dry Powder Inhalation Excipients Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Dry Powder Inhalation Excipients Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Protheragen-ING
11.1.1 Protheragen-ING Company Information
11.1.2 Protheragen-ING Overview
11.1.3 Protheragen-ING Dry Powder Inhalation Excipients Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Protheragen-ING Dry Powder Inhalation Excipients Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Protheragen-ING Recent Developments
11.2 DFE Pharma
11.2.1 DFE Pharma Company Information
11.2.2 DFE Pharma Overview
11.2.3 DFE Pharma Dry Powder Inhalation Excipients Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 DFE Pharma Dry Powder Inhalation Excipients Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 DFE Pharma Recent Developments
11.3 Meggle-Pharma
11.3.1 Meggle-Pharma Company Information
11.3.2 Meggle-Pharma Overview
11.3.3 Meggle-Pharma Dry Powder Inhalation Excipients Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Meggle-Pharma Dry Powder Inhalation Excipients Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Meggle-Pharma Recent Developments
11.4 Pfanstiehl
11.4.1 Pfanstiehl Company Information
11.4.2 Pfanstiehl Overview
11.4.3 Pfanstiehl Dry Powder Inhalation Excipients Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Pfanstiehl Dry Powder Inhalation Excipients Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfanstiehl Recent Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Overview
11.5.3 Merck Dry Powder Inhalation Excipients Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Merck Dry Powder Inhalation Excipients Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Recent Developments
11.6 Sheffield (Kerry)
11.6.1 Sheffield (Kerry) Company Information
11.6.2 Sheffield (Kerry) Overview
11.6.3 Sheffield (Kerry) Dry Powder Inhalation Excipients Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Sheffield (Kerry) Dry Powder Inhalation Excipients Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sheffield (Kerry) Recent Developments
11.7 Armor Pharma
11.7.1 Armor Pharma Company Information
11.7.2 Armor Pharma Overview
11.7.3 Armor Pharma Dry Powder Inhalation Excipients Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Armor Pharma Dry Powder Inhalation Excipients Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Armor Pharma Recent Developments
11.8 Abbott
11.8.1 Abbott Company Information
11.8.2 Abbott Overview
11.8.3 Abbott Dry Powder Inhalation Excipients Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Abbott Dry Powder Inhalation Excipients Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Abbott Recent Developments
11.9 Norvatis
11.9.1 Norvatis Company Information
11.9.2 Norvatis Overview
11.9.3 Norvatis Dry Powder Inhalation Excipients Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Norvatis Dry Powder Inhalation Excipients Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Norvatis Recent Developments
11.10 Bayer
11.10.1 Bayer Company Information
11.10.2 Bayer Overview
11.10.3 Bayer Dry Powder Inhalation Excipients Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Bayer Dry Powder Inhalation Excipients Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bayer Recent Developments
11.11 Jiangsu Daoning Drug
11.11.1 Jiangsu Daoning Drug Company Information
11.11.2 Jiangsu Daoning Drug Overview
11.11.3 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jiangsu Daoning Drug Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dry Powder Inhalation Excipients Industry Chain Analysis
12.2 Dry Powder Inhalation Excipients Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dry Powder Inhalation Excipients Production Mode & Process
12.4 Dry Powder Inhalation Excipients Sales and Marketing
12.4.1 Dry Powder Inhalation Excipients Sales Channels
12.4.2 Dry Powder Inhalation Excipients Distributors
12.5 Dry Powder Inhalation Excipients Customers
13 Dry Powder Inhalation Excipients Market Dynamics
13.1 Dry Powder Inhalation Excipients Industry Trends
13.2 Dry Powder Inhalation Excipients Market Drivers
13.3 Dry Powder Inhalation Excipients Market Challenges
13.4 Dry Powder Inhalation Excipients Market Restraints
14 Key Findings in the Global Dry Powder Inhalation Excipients Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1817 million in 2025 to US$ 2613 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 159
USD 4900.00
(Single User License)
The global Dry Powder Inhalation Excipients market size was US$ 1817 million in 2025 and is forecast to reach a readjusted size of US$ 2613 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 99
USD 4250.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1817 million in 2025 and is projected to reach US$ 2613 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 123
USD 3950.00
(Single User License)
The global Dry Powder Inhalation Excipients market was valued at US$ 1817 million in 2025 and is anticipated to reach US$ 2613 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 124
USD 2900.00
(Single User License)
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1733 million in 2024 to US$ 2491 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 159
USD 4900.00
(Single User License)
The global Dry Powder Inhalation Excipients market size was US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 92
USD 4250.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 127
USD 3950.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was valued at US$ 1733 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-03-13
Pages: 97
USD 2900.00
(Single User License)
The global Dry Powder Inhalation Excipients revenue was US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 133
USD 4350.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was valued at US$ 1674 million in the year 2023 and is projected to reach a revised size of US$ 2376 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-01-01
Pages: 91
USD 2900.00
(Single User License)
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1817 million in 2025 to US$ 2613 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 159
The global Dry Powder Inhalation Excipients market size was US$ 1817 million in 2025 and is forecast to reach a readjusted size of US$ 2613 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 99
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1817 million in 2025 and is projected to reach US$ 2613 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-01-19
Pages: 123
The global Dry Powder Inhalation Excipients market was valued at US$ 1817 million in 2025 and is anticipated to reach US$ 2613 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-01-08
Pages: 124
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1733 million in 2024 to US$ 2491 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 159
The global Dry Powder Inhalation Excipients market size was US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 92
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 127
The global market for Dry Powder Inhalation Excipients was valued at US$ 1733 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-03-13
Pages: 97
The global Dry Powder Inhalation Excipients revenue was US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the review period (2024-2030).
Published: 2025-01-01
Pages: 133
The global market for Dry Powder Inhalation Excipients was valued at US$ 1674 million in the year 2023 and is projected to reach a revised size of US$ 2376 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-01-01
Pages: 91
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now